REHOVOT, Israel, Sept. 11, 2019 /PRNewswire/ -- Lavie Bio, a subsidiary of Evogene (NASDAQ: EVGN) (TASE: EVGN), focusing on improving food quality, agricultural sustainability and productivity through the development of novel microbiome based agriculture biological products, today announced the nomination of several notable industry ex

TAIZHOU, China, Sept. 11, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and 

SAN DIEGO, Sept. 11, 2019 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, announced that Andreas Muehler, M.D., Chief Medical Officer of Immunic, will pr

JUPITER, Fla., Sept. 11, 2019 /PRNewswire/ -- Excel Medical, an innovator in modernizing cardiac telemetry and medical device integration (MDI), today announced it entered into a collabor

PHOENIX, Sept. 11, 2019 /PRNewswire/ -- University of Phoenix today announced findings from their third annual first responders' survey regarding perceptions about mental health. The online survey conducted by The Harris Poll on behalf of the University finds that first responders continue to believe mental health is as important as

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Sept. 11, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for Trevyent® (treprostinil) for the treatment of pulmonary arterial hypertension (PA

PLANO, Texas, Sept. 11, 2019 /PRNewswire/ -- VitalTech™, an industry leader in connected health and remote patient monitoring, announced the closing of their Series A financing round from two strategic investors:  Concord Health Partners, a healthcare focused investment firm, and Stanley Ventures, the investment arm of

BRIDGEWATER, N.J., Sept. 11, 2019 /PRNewswire/ -- Nevakar Inc., a privately-held, late-stage specialty pharmaceutical company dedicated to developing innovative ophthalmic products, announced toda

SHANGHAI, Sept. 11, 2019 /PRNewswire/ -- According to Morgan Stanley Capital International's (MSCI) latest set of ESG ratings, 3SBio has been upgraded to BBB status, surpassing that of 61% of companies in the global biotechnology industry.MSCI ESG ratings focus on ESG issues that have a substantial impact on the industry at the environmental, social an

Not intended for UK-based media  DARMSTADT, Germany, Sept. 11, 2019 /PRNewswire/-- Merck KGaA, Darmstadt, Germany, a leading science and technology company, which operates its biopharmaceutical business as EMD Serono in the US and Canada, today announced that the US Food and